Journal
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
Volume 22, Issue 18, Pages -Publisher
MDPI
DOI: 10.3390/ijms221810029
Keywords
synergistic effect; melanoma; histone deacetylase inhibitor (HDACi); combination therapy; drug sequential order
Funding
- Ministry of Science and Technology, Taiwan [MOST 109-2314B-195-019]
- MacKay Memorial Hospital, Taiwan [MMH-TH-10908, MMH-TH-11006]
- National Tsing Hua University, Taiwan [110Q2521E1, 109Q2523E1]
Ask authors/readers for more resources
Sequential administration and effective dosing of VPA-ETO combination therapy induced different cellular responses in melanoma cells, with simultaneous combined treatment showing synergistic inhibitory effects through enhanced DNA double-strand breaks and compromised homologous recombination, and sequential combined treatment with ETO pretreatment leading to enhanced apoptosis. Surprisingly, pretreated sequential combined treatment with VPA resulted in an antagonistic effect due to enhanced homologous recombination activity and G2/M phase arrest.
Melanoma is the most lethal form of skin cancer, which is intrinsically resistant to conventional chemotherapy. Combination therapy has been developed to overcome this challenge and show synergistic anticancer effects on melanoma. Notably, the histone deacetylase inhibitor, valproic acid (VPA), has been indicated as a potential sensitizer of chemotherapy drugs on various metastatic cancers, including advanced melanoma. In this study, we explored whether VPA could serve as an effective sensitizer of chemotherapy drug etoposide (ETO) on B16-F10 and SK-MEL-2-Luc melanoma cell lines in response to drug-induced DNA damages. Our results demonstrated that the VPA-ETO simultaneous combined treatment and ETO pretreated sequential combined treatment generated higher inhibitory effectivities than the individual treatment of each drug. We found the VPA-ETO simultaneous combined treatment contributed to the synergistic inhibitory effect by the augmented DNA double-strand breaks, accompanied by a compromised homologous recombination activity. In comparison, the ETO pretreated sequential combined treatment led to synergistic inhibitory effect via enhanced apoptosis. Surprisingly, the enhanced homologous recombination activity and G2/M phase arrest resulted in the antagonistic effect in both cells under VPA pretreated sequential combined treatment. In summary, our findings suggested that sequential order and effective dose of drug administration in VPA-ETO combination therapy could induce different cellular responses in melanoma cells. Such understanding might help potentiate the effectiveness of melanoma treatment and highlight the importance of sequential order and effective dose in combination therapy.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available